Health Care Biogen Inc. (BIIB) Q2 2022 Earnings Call Transcript 4 years ago Biogen Inc. (NASDAQ: BIIB) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Michael Hencke -- Head of Investor Relations. Michel… Anthem, Inc. (ANTM) Q2 2022 Earnings Call Transcript 4 years ago Anthem, Inc. (NYSE: ANTM) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Stephen Tanal -- Vice President, Investor Relations Gail… Johnson & Johnson (JNJ) Q2 2022 Earnings Call Transcript 4 years ago Johnson & Johnson (NYSE: JNJ) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Jessica Moore -- Vice President, Investor Relations… Novartis AG (NVS) Q2 2022 Earnings Call Transcript 4 years ago Novartis AG (NYSE: NVS) Q2 2022 earnings call dated Jul. 19, 2022 Corporate Participants: Samir Shah -- Global Head of Investor Relations… Abbott Laboratories (ABT) Earnings: 2Q22 Key Numbers 4 years ago Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an… Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results 4 years ago Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net… UnitedHealth Group Incorporated (UNH) Q2 2022 Earnings Call Transcript 4 years ago UnitedHealth Group Incorporated (NYSE: UNH) Q2 2022 earnings call dated Jul. 15, 2022 Corporate Participants: Andrew Witty -- Chief Executive Officer Dirk… Organigram Holdings Inc. (OGI) Q3 2022 Earnings Call Transcript 4 years ago Organigram Holdings Inc. (NASDAQ: OGI) Q3 2022 earnings call dated Jul. 14, 2022 Corporate Participants: Craig MacPhail -- Group Director Beena Goldenberg -- Chief… What awaits Johnson & Johnson (JNJ) beyond consumer business spinoff 4 years ago Johnson & Johnson (NYSE: JNJ) is probably the most diversified healthcare firm that owns several popular consumer brands, which have… Despite generic threat, AbbVie (ABBV) remains a good long-term bet 4 years ago Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from… Next» « Previous